Ozempic and Wegovy, GLP-1 weight loss drugs, have risen in popularity and are grabbing the attention of orthopedic surgeons.
Featured Insights
Paul Tornetta III, MD, PhD, has been involved with the American Academy of Orthopaedic Surgeons for more than 25 years, and he's seen how the orthopedic landscape and its challenges have changed.
Rothman Orthopaedic Specialty Hospital in Bensalem, Pa. was ranked as the best hospital in the state for joint replacement, and a key factor to achieving that honor lies in a holistic approach to care, according to Max Courtney, MD.
Allowing physicians to have ownership in the places they work can make ASCs more attractive in recruiting, spine surgeon Stephen Hochschuler, MD, said.
The popularity of glucagon-like peptide-1 receptor agonists like Ozempic has skyrocketed over the past few years.
Physician recruitment isn't the only obstacle for spine practices and health systems. Surgical technicians have been another challenging position to recruit for.
The continuing wave of orthopedic and spine procedures to ASC settings has one surgeon concerned about the impact that will have on both surgeons and patients.
Physician recruiting can be a challenge for healthcare groups, but outpatient settings might have an advantage when it comes to bringing on spine surgeons.
The increasing movement of procedures to ASCs settings, biologics and new technologies are three trends that orthopedic surgeons are keeping up with.
Spine surgery robots have the advantage of assisting physicians with procedure planning and increased precision and can bolster patient recovery.
